| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6269bcd01609187bfb81806312590a9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-90287
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4742
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70589 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6871
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 |
| filingDate |
2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f4af6ac7d6bb350c196547c256af3c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35e212ba982e421abee4e9b84989df92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b53c88baecb766a10c4f73ac7c583376
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5414ba3d1a254b1ce874a5b7eb055ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1954826e67e3507f46b335b9539b2726 |
| publicationDate |
2021-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113552350-A |
| titleOfInvention |
Compositions and methods for prostate cancer analysis |
| abstract |
The present invention relates to compositions and methods for prostate cancer analysis. The present invention provides methods for diagnosing prostate cancer based on the detection of STEAP1 on Circulating Tumor Cells (CTCs) using Tyramine Signal Amplification (TSA). The invention also provides methods of determining the prognosis and efficacy of STEAP1-ADC therapy in patients with prostate cancer, particularly metastatic castration resistant prostate cancer (mCRPC). |
| priorityDate |
2015-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |